Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study
Status
Conditions
Treatments
Details and patient eligibility
About
This is a pilot study to test the hypothesis that biofeedback-mediated stress management (BFSM) training can be used to reduce distress and enhance quality of life in patients with non-small cell lung cancer (NSCLC). Most patients with advanced NSCLC have significant physical symptoms, but even those who do not have physical symptoms have high levels of anxiety and depression.
Full description
Biofeedback-mediated stress management (BFSM) involves helping patients to visualize the reactions which their own bodies have to stressful situations (increased heart rate, increased skin conductance, increased muscle tension, decreased digital peripheral temperature, decreased heart rate variability) and then teaching them to control these reactions, using standard stress management and relaxation techniques, coupled with computerized physiological feedback. The feedback helps patients to understand that deep relaxation is helping their bodies as well as their minds. Several small studies of BFSM training in cancer populations have been successful at helping with side effects of chemotherapy and radiation, but the effects of BFSM on distress and quality of life (QOL), particularly in NSCLC patients, have not been studied.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients with a new diagnosis of advanced (stage IV) non-small cell lung cancer (NSCLC)
- ECOG performance status 0-1.
- Plan to receive care at the Taussig Cancer Center.
Exclusion criteria
- Non-local patients, who will not have the ability to return for 8 study visits.
- Patients who are unable to speak and understand English readily,
- Patients with significant cognitive impairment.
Trial design
Primary purpose
Allocation
Interventional model
Masking
8 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal